DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
PF-04457845 is an investigational drug.
There have been 9 clinical trials for PF-04457845. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2014.
The most common disease conditions in clinical trials are Osteoarthritis, Knee, Osteoarthritis, and Stress Disorders, Traumatic. The leading clinical trial sponsors are Pfizer, Yale University, and Tourette Association of America.
Recent Clinical Trials for PF-04457845
|A Study To Assess the Effects Of PF-04457845 On BOLD fMRI In Subjects With Post Traumatic Stress Disorder||Pfizer||Phase 2|
|FAAH Inhibitor Trial for Adults With Tourette Syndrome||Tourette Association of America||Phase 2|
|FAAH Inhibitor Trial for Adults With Tourette Syndrome||Yale University||Phase 2|